Home
ImprimisRX

ImprimisRX Market Share Analysis for June 2026

Health > Pharmacy

Domainimprimisrx.com

Year Founded2012

Employees51 - 200

Annual Revenue$15M - $25M

ImprimisRX

ImprimisRX (including company regionals)

imprimisrx.com

See more website traffic and engagement information

ImprimisRX Revenue up to June 2026 is 15M - 25M

revenue generated by ImprimisRX top domains

ImprimisRX top domains revenue over 3 years

Revenue for ImprimisRX top domains

imprimisrx.com15M - 25M

See more with Sales Intelligence

Total visits to ImprimisRX's top domains

Understand ImprimisRX market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

imprimisrx.com17.3K

See more with Sales Intelligence

Avg. visit duration in ImprimisRX's top domains

Analyze ImprimisRX engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

imprimisrx.com00:01:41

See more with Sales Intelligence

Avg. pageviews on ImprimisRX's top domains

See how ImprimisRX keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

imprimisrx.com1.98

See more with Sales Intelligence

ImprimisRX top competitors by domain

Top similar sites in June 2026, ranked by their affinity

fagronsterile.comCompany NameFagron Sterile ServicesEmployees201 - 500HQUnited States, Kansas, WichitaAnnual revenue$2M - $5MTotal visits6.6KN/A

Top technologies used by ImprimisRX

These are the website technologies, by industry, used by ImprimisRX top domains

Audio Video Media (5)

Vimeo

Payment & Currencies (5)

PayPal

Marketing (4)

Google Marketing Platform

Widget (4)

Twemoji

More Technologies

13

See all

News & Signals from ImprimisRX

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsImprimisRx, LLC launched DuoClear on Jan 1st '23.In 2023, Imprimis Pharmaceuticals announced the launch of its new topical wart treatment, DuoClear®.

NewsImprimisRx, LLC launched Fortisite on Sep 29th '22.ImprimisRx announced the availability of Fortisite, which includes a patent-pending compounded combination of Tobramycin 1.5% and Vancomycin 5%.

NewsImprimisRx, LLC partnered with Doxy.me Inc. on Mar 1st '20.ImprimisRx has entered into an exclusive agreement with Doxy.me, a full-service telemedicine software solution, to provide ophthalmologists, optometrists, and wellness providers telecare abilities at no charge.